Agios Pharmaceuticals, Inc. (AGIO)
33.46
+0.54
(+1.64%)
USD |
NASDAQ |
Apr 13, 10:05
Agios Pharmaceuticals EPS Diluted (Quarterly) : -1.852 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Biogen, Inc. | -0.3333 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| Apellis Pharmaceuticals, Inc. | -0.4654 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -108.04M |
| Revenue (Quarterly) | 19.97M |
| Total Expenses (Quarterly) | 128.01M |
| Enterprise Value | 1.115B |
| Gross Profit Margin (Quarterly) | 84.25% |
| Profit Margin (Quarterly) | -541.1% |
| Earnings Yield | -21.28% |
| Normalized Earnings Yield | -21.28 |